Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1

Author： Rygiel Tomasz P   Luijk Bart   Meyaard Linde  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.3, 2013-03, pp. : 389-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1

By Winum Jean-Yves  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 757-760

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic compounds: patent evaluation of WO2011011652A1

By Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1491-1495

Informa Healthcare

Access to resources Recommend Favorite

Antagonists of IL-1R: a patent evaluation (WO2012122985)

By Sette Claudio  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 911-914

Informa Healthcare

Access to resources Recommend Favorite

Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1

By Chiurchiù Valerio   Maccarrone Mauro   Orlacchio Antonio  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 2, 2012-02 ,pp. : 181-184

Informa Healthcare

Access to resources Recommend Favorite

Anti-CD20 Antibody in Primary Sjogren’s Syndrome Management

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 535-541

Bentham Science Publishers

Access to resources Recommend Favorite